BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,89 € ↓ -2,21 (-4,50%)
2026-06-02
DEL PRIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership359,702 shares
Latest Disclosed Value $ 20,319,566
Squarepoint Ops LLC ownership in BM8 / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 359,702 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $17,258,502 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,828,344 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -80.33% during the quarter. The current value of the position is $16,866,427 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (BM8) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BM8 / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 359,702 -1,468,642 -80.33 20,320 -81.30 0.0239
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,828,344 439,820 31.68 108,658 44.49 0.1156
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,388,524 -283,923 -16.98 75,202 -18.20 0.0756
2025-08-27 2025-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,672,447 283,719 20.43 91,934 -6.35 0.0956
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,672,447 283,719 91,934 0.0956
2025-08-27 2025-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 1,388,728 695,590 100.35 98,169 115.48 0.1191
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,388,728 695,590 98,169 0.1191
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 693,138 488,612 238.90 45,560 216.91 0.0449
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 204,526 100,841 97.26 14,376 68.42 0.0225
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 103,685 -757,532 -87.96 8,536 -88.65 0.0141
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 861,217 582,506 209.00 75,219 179.90 0.1294
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 278,711 -177,477 -38.90 26,873 -33.42 0.0509
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 456,188 138,897 43.78 40,364 46.76 0.0997
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 317,291 145,932 85.16 27,503 65.06 0.0842
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 171,359 -3,774 -2.15 16,663 -8.07 0.0679
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 175,133 151,541 642.34 18,125 806.20 0.0716
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 23,592 23,592 2,000 0.0101
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -218,758 -100.00 0 -100.00
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 218,758 -38,713 -15.04 16,866 -25.86 0.0722
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 257,471 60,156 30.49 22,748 49.17 0.0601
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 197,315 108,567 122.33 15,250 105.94 0.0438
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 88,748 -37,305 -29.59 7,405 -22.20 0.0282
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 126,053 68,303 118.27 9,518 87.95 0.0558
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 57,750 31,884 123.27 5,064 157.32 0.0378
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,866 -43,736 -62.84 1,968 -77.08 0.0265
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 69,602 -51,583 -42.57 8,585 -16.16 0.1389
2020-05-15 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 121,185 -241,492 -66.59 10,240 -66.61 0.2619
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 362,677 301,244 490.36 30,664 640.50 0.1824
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 61,433 -58,184 -48.64 4,141 -59.58 0.0370
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 119,617 13,582 12.81 10,245 8.77 0.0998
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 106,035 101,802 2,404.96 9,419 2,516.39 0.0997
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,233 4,233 360 0.0042
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -55,529 -100.00 0 -100.00
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 55,529 55,529 5,168 0.0994
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -2,800 -100.00 0 -100.00
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,800 -8,327 -74.84 259 -70.09 0.0172
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 11,127 11,127 0.00 866 0.0540
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -6,800 -100.00 0 -100.00
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,800 -798 -10.50 712 -11.00 0.0781
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,598 7,598 0.00 800 0.1996
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -7,200 -100.00 0 -100.00
2015-05-19 2015-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 7,200 7,200 897 0.3141
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,200 897 0.3141
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 6,900 -79.71 410 -77.73 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 34,000 -35.24 1,841 -36.19 n/a n/a n/a
2025-08-27 2025-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 52,500 141.94 2,886 88.19 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 52,500 2,886 n/a n/a n/a
2025-08-27 2025-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Call 21,700 -72.46 1,534 -70.40 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 21,700 1,534 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 78,800 -17.05 5,180 -22.44 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 95,000 110.64 6,678 79.83 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 45,100 1,634.62 3,713 1,535.68 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 2,600 -91.39 227 -92.20 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 30,200 2,912 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 6,100 539 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-27 2025-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 10,500 -65.69 577 -73.32 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 10,500 577 n/a n/a n/a
2025-08-27 2025-03-31 13F/A BIOMARIN PHARMACEUTICAL COM Put 30,600 -40.81 2,163 -36.34 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,600 2,163 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 51,700 338.14 3,398 309.89 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 11,800 -62.66 829 -68.13 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 31,600 1,115.38 2,602 1,045.81 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 2,600 -91.36 227 -92.18 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 30,100 2,902 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,100 539 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.